The next-generation sequencing market size is poised to grow by $ 24.48 billion by 2030 from $ 7.37 Billion in 2022, exhibiting a CAGR of 16.1% during the forecast period 2022 to 2030.
Key Takeaway:
- By application, the oncology segment accounted 28.8% revenue share in 2021.
- By technology, the targeted sequencing and resequencing segment accounted 75% revenue share in 2021.
- The sequencing segment harnered market share of over 54.9% in 2021.
- North America region hit revenue share of over 49.4% in 2021.
The main objective of this report is to define, describe, and forecast the global market by types, application, manufacturers, and regions. The report provides detailed information about the major factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the market. The report aims to strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market. The report also attempts to forecast the market size of the 5 main regions: North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It strategically profiles the key market players and comprehensively analyzes their core competencies. It also tracks and analyzes competitive developments, such as joint ventures, mergers and acquisitions, new developments, and Research and Development (R&D) activities, in market.
Get a Sample: https://www.precedenceresearch.com/sample/1454
COVID-19 Impact
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the electric vehicle fuel cell market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Major companies operating in this are
- BGI Group
- F. Hoffmann-La Roche AG
- Pacific Biosciences of California Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Precigen Inc.
- Illumina Inc.
- Qiagen N.V.
- PerkinElmer Inc.
- PierianDx Inc.
Market Segmentation
By Product
- NGS Consumables
- Sequencing Services
- Exome & Targeted Resequencing & Custom Panels
- Whole-Genome Sequencing & De Novo Sequencing
- RNA Sequencing
- Other Sequencing Services
- Presequencing Products & Services
- Library Preparation & Target Enrichment
- Quality Control
- NGS Platforms
- Illumina
- Novaseq Systems
- Nextseq Systems
- Miseq Systems
- Miniseq Systems
- iSeq Systems
- Thermo Fisher Scientific
- ION PGM Systems
- ION Proton Systems
- ION Genestudio Systems
- Ion Torrent Genexus Systems
- Oxford Nanopore Technologies
- Pacific Biosciences
- Other Platforms
- Illumina
- Bioinformatics
- Data Analysis Services
- NGS Data Analysis Software & Workbenches
- NGS Storage, Management, & Cloud Computing Solutions
- Services for NGS Platforms
By Application
- Diagnostics
- Cancer Diagnostics
- Infectious Disease Diagnostics
- Reproductive Health Diagnostics
- Other Diagnostic Applications
- Biomarkers and Cancer
- Reproductive Health
- NIPT
- Aneuploidy
- Microdeletions
- PGT
- Newborn Genetic Screening
- Single Gene Analysis
- Personalized Medicine
- Agriculture and Animal Research
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Consumer Genomics
- Others
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Others
By End User
- Academic and Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Clinical Research
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Major highlights of Report:
- Figures related to sales volume, market remuneration, and segmental shares
- Featuring market dynamics
- Growth prospects and expansion graph
- PROCON study of direct & indirect sales channels
- Profiles of prominent traders, dealer, and distributors in the industry
Geographical landscape: North America, Europe, Asia-Pacific, South America, Middle East and Africa
- Industry forecasts based on region and at country level
- Data about sales volume recorded, industry share held, and profit margins amassed
- Overall remuneration and estimated growth rate for each regional market
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Next Generation Sequencing Market
5.1. COVID-19 Landscape: Next Generation Sequencing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Next Generation Sequencing Market, By Product
8.1. Next Generation Sequencing Market, by Product Type, 2021-2030
8.1.1. Consumables Platforms
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Services and Nerve Blockers
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Next Generation Sequencing Market, By Application
9.1. Next Generation Sequencing Market, by Application, 2021-2030
9.1.1. Diagnostics
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Biomarkers and Cancer
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Reproductive Health
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Personalized Medicine
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Agriculture and Animal Research
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Next Generation Sequencing Market, By Technology Type
10.1. Next Generation Sequencing Market, by Technology Type, 2021-2030
10.1.1. Sequencing by Synthesis
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Ion Semiconductor Sequencing
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Sequencing by Ligation
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Pyrosequencing
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Single Molecule Real Time Sequencing
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Next Generation Sequencing Market, By End User Type
11.1. Next Generation Sequencing Market, by End User Type, 2021-2030
11.1.1. Academic and Research Centers
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Pharmaceutical and Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Hospitals and Clinics
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Clinical Research
11.1.4.1. Market Revenue and Forecast (2019-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Next Generation Sequencing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.1.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.2.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.3.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.4.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)
12.5.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
Chapter 13. Company Profiles
13.1. BGI Group
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann-La Roche AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Pacific Biosciences of California Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Agilent Technologies Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Precigen Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Illumina Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Qiagen N.V.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. PerkinElmer Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. PierianDx Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments